Eosinophilic esophagitis (EoE) is not a common differential diagnosis in patients with longstanding refractory gastroesophageal reflux disease (GERD). The aim of this retrospective analysis was to assess the prevalence of EoE in patients with refractory GERD.
This retrospective analysis was performed in the Gastroenterology Department of a tertiary care institute in Karachi, Pakistan. Records of esophagogastroduodenoscopy (EGD) with esophageal biopsy from January 2016 till December 2018 were included.
There were 16 (7.7%) patients of refractory GERD diagnosed with EoE. There were more females than males (5:3). The median age was 58 years (range: 41-63 years). Dysphagia was the chief complaint leading to EGD followed by food impaction and heartburn. The median duration of symptoms was 46.5 months (range: 22-65 months). Erosive esophagitis, white plaques, and friability are common endoscopic findings; however, strictures are also not uncommon.
Eosinophilic esophagitis is not uncommon in patients with refractory GERD. It may present with dysphagia, heartburn, and food impaction. Old patients with longstanding GERD, positive for atopy, not responding to gastric acid inhibitors must be considered for EoE screening via EGD and esophageal biopsy.
Eosinophilic esophagitis (EoE) is an allergen/immune-mediated disease. It is characterized by eosinophilic infiltration (≥15/high-power field, HPF) of the esophageal mucosa. EoE presents with symptoms of esophageal dysfunction and is a major cause of food impaction, heartburn, chest burn, and dysphagia. At present, it has an incidence of 5-10 cases per 100,000 people and a prevalence of 0.5-1 case per 1000 in the general population [1,2]. The endoscopic findings in EoE include concentric rings, longitudinal furrows, white exudates or plaques and friability. Narrowing of the lumen and strictures represent severe disease .
Initially EoE was described in pediatrics and then in adults only recently. Over the years, a gradual increase has been observed in the incidence of EoE, which may be due to changing genetics and the environment or due to more careful search for the disease . The prevalence of EoE may still be low in the general population, however, in patients with dysphagia it may be as high as 12% and 48% in patients with food impaction [4, 5]. In as many as 30% cases, EoE may be associated with gastroesophageal reflux disease (GERD) . Although, the clinical picture of EoE and GERD maybe overlapping, both have been established as separate disease entities. However, eosinophilic infiltration has been observed in the esophageal mucosa of patients with GERD and EoE has also been established as a secondary cause of GERD. Where patients with GERD respond to gastric acid inhibitors, EoE responds well to topical steroids . Hence, the suspicion of EoE must be raised in patients with GERD who do not respond to gastric acid inhibitors.
This study hypothesized that GERD patients with failed response to either proton pump inhibitors (PPIs) and/or H2 receptor antagonists (H2RA) may have underlying EoE. For this purpose, a retrospective analysis was done to assess the prevalence of EoE in nonresponsive patients of GERD.
Materials & Methods
The endoscopy and biopsy records of the Gastroenterology Department in a tertiary care institute in Karachi, Pakistan were searched for esophagogastroduodenoscopy (EGD) with esophageal biopsy from January 2015 till December 2017. All records of esophageal biopsies performed in known cases of refractory GERD (non-responsive to Proton pump inhibitors for more than one month) were included in this analysis. Patient age, gender, clinical characteristics, endoscopic findings, and eosinophil count were obtained. Patients with neoplasia, peptic ulcer, surgery of the gastrointestinal (GI) tract, inflammatory bowel disease (IBD), Behcet's disease, fungal esophagitis, eosinophilic gastroenteritis, and with no records of eosinophil count were excluded. This study was approved by the institutional ethics committee. The maximum count of eosinophils/HPF from all specimens was determined as the peak count. Patients with eosinophils ≥15 /HPF in at least one HPF were identified as having EoE. Data was entered and analyzed using Microsoft Excel 2013.
During the study period, a total of 4,345 EGDs were performed. There were 209 esophageal biopsies performed in patients with refractory GERD. Of these patients, 16 (7.7%) were diagnosed with EoE (eosinophils ≥15/HPF).
There were more females than males (5:3). The median age was 58 years (range: 41-63 years). All, except one male, had history of atopy. Dysphagia was the chief complaint leading to EGD followed by food impaction and heartburn. The median duration of symptoms was 46.5 months (range: 22-65 months). Erosive esophagitis was present in 9/16 (56.25%) patients. The characteristics of these eight patients are shown in Table 1.
The results of this analysis showed that the incidence of eosinophilic esophagitis in adult patients with refractory GERD was approximately 8%. Dysphagia, food impaction, and heartburn were the common symptoms. Erosive esophagitis was commonly seen on endoscopy. EoE must be considered as a differential diagnosis in patients not responding to the medical management of GERD.
Our analysis is the first in terms of EoE prevalence in refractory GERD patients. However, our analysis was retrospective which comes with recall bias. To the best of our knowledge, the first report on EoE from Pakistan was published in 2011 . The incidence of EoE among patients undergoing upper gastrointestinal endoscopy for any reason was reported to be 7.4%. There were more males and the patients were younger. There was history of atopy, complaint of dysphagia and food impaction, and all patients had ‘feline esophagus’ on endoscopy with micro-abscesses seen in some .
Chronic acid exposure in GERD results in esophageal mucosal injury and inflammation which leads to mild eosinophilia. Since GERD is extremely common in the general population, the coexistence of EoE and GERD due to chance alone is plausible. In patients with EoE, chronic acid exposures have been documented by pH studies which strengthens the notion that EoE may result after longstanding GERD. However, EoE may also lead to GERD. This hypothesis is based on the fact that eosinophils disintegrate the mucosal barrier and esophageal smooth muscles leading to remodeling. Remodeling effect, in turn, makes the lower esophageal sphincter lax and impairs acid clearance leading to symptoms of GERD .
There have been few studies which report the coexistence of GERD and EoE. The incidence of EE in patients with GERD has been variable. In a Mexican study, 4% cases of refractory GERD were diagnosed with EoE on endoscopy. They compared the characteristics of patients with and without EoE and found that patients with EoE were significantly younger, had significantly more dysphagia, atopy, ineffective esophageal peristalsis, esophageal rings and esophageal strictures than patients without EoE. They reported age < 45 years, dysphagia, and atopy as independent predictors of EoE . In an Iranian study, the prevalence of EoE in cases of refractory GERD was 8.8%. All patients reported atopy and the common endoscopic findings were erosive esophagitis, rings, and white plaques .
In a Japanese study, 6% patients with GERD, and 9.7% with PPI-refractory GERD, were diagnosed with EoE. Heartburn and dysphagia were typical symptoms. However, in their study only one out of six diagnosed patients had typical endoscopic findings (longitudinal furrows) and the endoscopy was unremarkable in all others. They failed to establish any significant differences between the characteristics of patients with and without EoE . In a study from Brazil, only 1/103 patients (0.97%) with PPI-refractory GERD was diagnosed with EoE. The patient was positive for atopy and endoscopy revealed esophageal mucosa corrugations . In a Korean study with patients with esophageal or UGI symptoms including dysphagia food impaction, acid regurgitation, heartburn, chest pain, epigastric pain, nausea and/or vomiting, EoE was diagnosed in 6.6%. Past history of GERD, allergic rhinitis, and atopic dermatitis were more common in EoE positive patients. Endoscopic findings in EoE positive patients included linear furrows, rings, and whitish papules .
In this study, 1/16 (6.25%) patient had narrowed esophageal lumen and a stricture was identified. To the best of our knowledge, only García-Compeán et al. reported the stricture and endoscopic finding in 2/6 (33.3%) of their patients with EoE. When compared with EoE negative patients, stricture was a statistically significant finding (p = 0.012) . Presence of esophageal strictures indicates advanced disease.
Although not very common, EoE should be an important differential diagnosis in patients with reflux symptoms and in patients not responding to gastric acid inhibitors. EoE has varying prevalence in different parts of the world and patients with refractory GERD are a high-risk group. Prompt EGD and biopsy should be performed for accurate diagnosis and adequate management. Patients with EoE respond well to topical corticosteroids.
Eosinophilic esophagitis is not uncommon in Pakistani patients with refractory GERD. These patients are old and most of them are females. These patients may present with dysphagia, heartburn, and food impaction. Erosive esophagitis, white plaques, and friability are common endoscopic findings; however, strictures are also not uncommon. Old patients with longstanding GERD, positive for atopy, not responding to gastric acid inhibitors must be considered for EoE screening via EGD and esophageal biopsy.
- Dellon ES, Hirano I: Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018, 154:319-332. 10.1053/j.gastro.2017.06.067
- Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH: Prevalence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China. J Dig Dis. 2012, 13:304-309. 10.1111/j.1751-2980.2012.00593.x
- García-Compeán D, González JA, García CA, et al.: Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011, 43:204-208. 10.1016/j.dld.2010.08.002
- Mackenzie SH, Go M, Chadwick B, et al.: Eosinophilic oesophagitis in patients presenting with dysphagia-a prospective analysis. Aliment Pharmacol Ther. 2008, 28:1140-1146. 10.1111/j.1365-2036.2008.03795.x
- Kerlin P, Jones D, Remedios M, Campbell C: Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007, 41:356-361. 10.1097/01.mcg.0000225590.08825.77
- Remedios M, Campbell C, Jones DM, Kerlin P: Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006, 63:3-12. 10.1016/j.gie.2005.07.049
- Saeed S, Zuberi BF, Afsar S, Qadeer R, Memon AR: Frequency of Eosinophilic Esophagitis in patients undergoing upper GI Endoscopy. Pak J Med Sci. 2011, 27:545-548.
- Wong S, Ruszkiewicz A, Holloway RH, Nguyen NQ: Gastro-oesophageal reflux disease and eosinophilic oesophagitis: what is the relationship?. World J Gastrointest Pathophysiol. 2018, 9:63-72. 10.4291/wjgp.v9.i3.63
- Foroutan M, Norouzi A, Molaei M, et al.: Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. Dig Dis Sci. 2010, 55:28-31. 10.1007/s10620-008-0706-z
- Okimoto K, Arai M, Ishigami H, et al.: A prospective study of eosinophilic esophagitis and the expression of tight junction proteins in patients with gastroesophageal reflux disease symptoms. Gut Liver. 2018, 12:30-37. 10.5009/gnl16600
- Sá CC, Kishi HS, Silva-Werneck AL, et al.: Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics. 2011, 66:557-561. 10.1590/S1807-59322011000400006
- Joo MK, Park JJ, Kim SH, et al.: Prevalence and endoscopic features of eosinophilic esophagitis in patients with esophageal or upper gastrointestinal symptoms. J Dig Dis. 2012, 13:296-303. 10.1111/j.1751-2980.2012.00589.x
Retrospective Analysis of Eosinophilic Esophagitis in Patients with Refractory Gastroesophageal Reflux Disease
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Dow University of Health Sciences issued approval OA/2018/012. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Anis K, Chandnani A, Ahmed M, et al. (July 27, 2019) Retrospective Analysis of Eosinophilic Esophagitis in Patients with Refractory Gastroesophageal Reflux Disease. Cureus 11(7): e5252. doi:10.7759/cureus.5252
Received by Cureus: July 08, 2019
Peer review began: July 10, 2019
Peer review concluded: July 24, 2019
Published: July 27, 2019
© Copyright 2019
Anis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.